Doptelet — Point32Health
Thrombocytopenia in chronic liver disease
Initial criteria
- Documented diagnosis of severe thrombocytopenia as indicated by a baseline platelet count less than 50,000/mcL
- Patient age ≥ 18 years
- Documentation the patient has chronic liver disease
- Documentation the patient is scheduled to undergo a medical procedure
- Prescribed by or in consultation with an appropriate specialist (e.g., hematologist, oncologist, immunologist, hepatologist, transplant specialist)
- For Mulpleta (lusutrombopag), documented trial and failure or contraindication to Doptelet (avatrombopag)
Approval duration
1 month (one-time fill)